The 2011 Medical Student Research Forum poster presentation took place on January 27 in the atrium of the Biomedical Education Building in the School of Medicine and Biomedical Sciences.
Researchers at UB have developed a novel technology that is expected to have implications for research and treatment of tuberculosis and other lung diseases.
A UB MD/PhD candidate is lead author on a paper describing how drug-resistant viruses may be thwarted by a potent, immune-boosting payload delivered to cells by gold nanorods.
A group of young entrepreneurs led by Krishnan Chakravarthy, an MD/PhD candidate in the school’s MD-PhD Program, has launched NanoAxis, a new research and development company headquartered in Getzville, New York.
